Naoxintong Capsule for Secondary Prevention of Ischemic Stroke: A Multicenter, Randomized, and Placebo-Controlled Trial

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

(2020) Theo Vos et al.   LANCET

Association of Body Mass Index and Risk of Stroke After Acute Minor Stroke or TIA: a Post Hoc Analysis of a Randomized Controlled Trial

(2019) Weiqi Chen et al.   NEUROTOXICITY RESEARCH

Protective effect of Danhong Injection combined with Naoxintong Capsule on cerebral ischemia-reperfusion injury in rats

(2018) Jiayang Wan et al.   JOURNAL OF ETHNOPHARMACOLOGY

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial

(2018) Philip M Bath et al.   LANCET

NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice

(2018) Shu Yang et al.   Scientific Reports

2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack

(2017) Yongjun Wang et al.   International Journal of Stroke

Comparison of Aspirin and Naoxintong Capsule (脑心通胶囊) with Adjusted-Dose Warfarin in Elderly Patients with High-Risk of Non-Valvular Atrial Fibrillation and Genetic Variants of Vitamin K Epoxide Reductase

(2016) Huan Wang et al.   Chinese Journal of Integrative Medicine

NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice

(2016) Xiaoxiao Yang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation

(2016) Yaqiong Wang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Metabolomics study on the effects of Buchang Naoxintong capsules for treating cerebral ischemia in rats using UPLC-Q/TOF-MS

(2016) Mengting Liu et al.   JOURNAL OF ETHNOPHARMACOLOGY

Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013

(2016) Maigeng Zhou et al.   LANCET

Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack

(2016) S. Claiborne Johnston et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) TrialCLINICAL PERSPECTIVE

(2015) Yilong Wang et al.   CIRCULATION

Fixed-Dose Combination Treatment After Stroke for Secondary Prevention in China: A National Community-Based Study

(2015) W. Longde et al.   STROKE

A randomized controlled trial of adjunctive Bunchang Naoxintong Capsule (步长脑心通胶囊) versus maintenance dose clopidogrel in patients with CYP2C19*2 polymorphism

(2014) Hui Chen et al.   Chinese Journal of Integrative Medicine

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

(2014) Walter N. Kernan et al.   STROKE

Naoxintong Protects against Atherosclerosis through Lipid-lowering and Inhibiting Maturation of Dendritic Cells in LDL Receptor Knockout Mice fed a High-fat Diet

(2013) Jingjing Zhao et al.   CURRENT PHARMACEUTICAL DESIGN

Association of Hypertension With Stroke Recurrence Depends on Ischemic Stroke Subtype

(2013) Yilong Wang et al.   STROKE

Standards of Medical Care in Diabetes--2013

(2012)   DIABETES CARE

Abnormal Glucose Regulation in Patients With Acute Stroke Across China

(2012) Qian Jia et al.   STROKE

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

(2008) Ralph L. Sacco et al.   NEW ENGLAND JOURNAL OF MEDICINE